Neuropathological relationship between major depression and dementia: A hypothetical model and review
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Major depression (MDD) is a chronic psychiatric condition in which patients often show increasing cognitive impairment with recurring episodes. Neurodegeneration may play an important component in the pathogenesis of MDD associated with cognitive complaints. In agreement with this, patients with MDD show decreased brain volumes in areas implicated in emotional regulation and cognition, neuronal and glial cell death as well as activation of various pathways that can contribute to cell death. Therefore, the aim of this review is to provide an integrative overview of potential contributing factors to neurodegeneration in MDD. Studies have reported increased neuronal and glial cell death in the frontal cortex, amygdala, and hippocampus of patients with MDD. This may be due to decreased neurogenesis from lower levels of brain-derived neurotrophic factor (BDNF), excitotoxicity from increased glutamate signaling, and lower levels of gamma-aminobutyric acid (GABA) signaling. In addition, mitochondrial dysfunction and oxidative stress are found in similar brain areas where evidence of excitotoxicity has been reported. Also, levels of antioxidant enzymes were reported to be increased in patients with MDD. Inflammation may also be a contributing factor, as levels of inflammatory cytokines were reported to be increased in the prefrontal cortex of patients with MDD. While preliminary, studies have also reported neuropathological alterations in patients with MDD. Together, these studies suggest that lower BDNF levels, mitochondrial dysfunction, oxidative stress, inflammation and excitotoxicity may be contributing to neuronal and glial cell death in MDD, leading to decreased brain volume and cognitive dysfunction with multiple recurrent episodes. This highlights the need to identify specific pathways involved in neurodegeneration in MDD, which may elucidate targets that can be treated to ameliorate the effects of disease progression in this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 2×
“While this is the only study that examined inflammatory cytokines in the post-mortem brain of patients with MDD, their findings are in agreement with studies that examined peripheral samples (Dowlati et al., 2010; Elovainio et al., 2009; Ford & Erlinger, 2004; Liukkonen et al., 2006).”
ResultA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 1×
“…of studies are reporting molecular and cellular alterations using post-mortem brains from patients with MDD, such as increased apoptosis, lower levels of neurotrophic factors, and lower number of neurons and glial cells (Catena-Dell'Osso et al., 2011; Duman & Monteggia, 2006; Maes et al., 2009).”
BackgroundCytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Mechanisms and Functional Implications of Adult Neurogenesis
Zhao, C., Deng, W., & Gage, F. H. (2008) · Cell · doi:10.1016/j.cell.2008.01.033 · Cited by 3,007
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 3×
“Indeed, glial cell density was found to be lower in the prefrontal cortex, anterior cingulate cortex, and amygdala of patients with MDD (Bowley, Drevets, Ongür, & Price, 2002; Cotter et al., 2002; Rajkowska et al., 1999).”
BackgroundResultUntreated Depression and Hippocampal Volume Loss
Sheline, Y. I., Gado, M. H., & Kraemer, H. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1516 · Cited by 1,180 · cited 1×
“Interestingly, antidepressants were shown to normalize hippocampal volume by promoting neurogenesis (Czéh & Lucassen, 2007; Sheline et al., 2003), possibly by increasing levels of brain-derived neurotrophic factor (BDNF) (Hashimoto, Shimizu, & Iyo, 2004).”
BackgroundLower Hippocampal Volume in Patients Suffering From Depression: A Meta-Analysis
Campbell, S., Marriott, M., Nahmias, C., & MacQueen, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.598 · Cited by 1,156
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 2×
“In fact, chronic administration of antidepressants was shown to normalize levels of BDNF in the brain and blood of patients with MDD (Brunoni, Lopes, & Fregni, 2008; Castrén, Võikar, & Rantamäki, 2007; Shimizu et al., 2003).”
BackgroundMaeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103 · cited 1×
“…have demonstrated improvement in depressive symptoms within 72 hours of administration of ketamine at a sub-anesthetic dose in treatment-resistant patients with major depression (Maeng et al., 2008), suggesting that hyperactivation of the glutamate system may be contributing to this disease.”
BackgroundBrunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846 · cited 1×
“…its metabolites in the anterior cingulate cortex, prefrontal cortex, amygdala, occipital cortex, and the hippocampus (Auer et al., 2000; Gigante et al., 2012; Hasler et al., 2007; Pfleiderer et al., 2003; Sanacora et al., 2004; Zhang et al., 2013), although the direction of change is inconsistent.”
BackgroundPostmortem studies in mood disorders indicate altered numbers of neurons and glial cells
Rajkowska, G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00950-1 · Cited by 822
GDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration
Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820
Role of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667
Uranova, N. A., Vostrikov, V. M., Orlovskaya, D. D., & Rachmanova, V. I. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00181-6 · Cited by 659
Cotter, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.386 · Cited by 634 · cited 4×
“Indeed, glial cell density was found to be lower in the prefrontal cortex, anterior cingulate cortex, and amygdala of patients with MDD (Bowley, Drevets, Ongür, & Price, 2002; Cotter et al., 2002; Rajkowska et al., 1999).”
BackgroundResultInfluentialKarege, F., Vaudan, G., Schwald, M., Perroud, N., & La Harpe, R. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.12.020 · Cited by 600
Pathogenesis of depression: Insights from human and rodent studies
Ménard, C., Hodes, G. E., & Russo, S. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.053 · Cited by 593
Ford, D. E., & Erlinger, T. P. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.9.1010 · Cited by 544 · cited 1×
“While this is the only study that examined inflammatory cytokines in the post-mortem brain of patients with MDD, their findings are in agreement with studies that examined peripheral samples (Dowlati et al., 2010; Elovainio et al., 2009; Ford & Erlinger, 2004; Liukkonen et al., 2006).”
ResultShelton, R. C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D. A., & Mirnics, K. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.52 · Cited by 511
Prevalence and predictors of recurrence of major depressive disorder in the adult population
Hardeveld, F., Spijker, J., De Graaf, R., Nolen, W. A., & Beekman, A. T. F. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01519.x · Cited by 486
Rao, J. S., Harry, G. J., Rapoport, S. I., & Kim, H. W. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.47 · Cited by 432
Self-citationRajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C. A., & Miguel-Hidalgo, J. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301234 · Cited by 430 · cited 2×
“Another closely related neurotransmitter implicated in MDD is GABA (Sibille & French, 2013), where reduction in GABA neurons were found in the post- mortem dorsolateral prefrontal cortex of patients with MDD (Rajkowska et al., 2007).”
BackgroundCzéh, B., & Lucassen, P. J. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0728-0 · Cited by 419
O'Brien, J. T. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2081 · Cited by 409
The role of cognitive impairment in general functioning in major depression
Baune, B. T., Miller, R., McAfoose, J., Johnson, M., Quirk, F., & Mitchell, D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2008.12.001 · Cited by 378 · cited 2×
“Cognitive impairment is a feature of major depression that was found to worsen with increasing number of episodes (Baune et al., 2010).”
BackgroundBernard, R., Kerman, I. A., Thompson, R. C., Jones, E. G., Bunney, W. E., Barchas, J. D., Schatzberg, A. F., Myers, R. M., Akil, H., & Watson, S. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.44 · Cited by 372 · cited 2×
“…density of α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid (AMPA) receptors in the anterior cingulate (Gibbons, Brooks, Scarr, & Dean, 2012) and altered expression levels of genes related to glutamate signaling, including SLC1A2, SLC1A3 and GLUL in the locus coeruleus (Bernard et al., 2011).”
BackgroundGlial reduction in amygdala in major depressive disorder is due to oligodendrocytes
Hamidi, M., Drevets, W. C., & Price, J. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.006 · Cited by 369
Bell-McGinty, S., Butters, M. A., Meltzer, C. C., Greer, P. J., Reynolds, C. F., & Becker, J. T. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1424 · Cited by 338
Treadway, M. T., Waskom, M. L., Dillon, D. G., Holmes, A. J., Park, M. T. M., Chakravarty, M. M., Dutra, S. J., Polli, F. E., Iosifescu, D. V., Fava, M., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.06.018 · Cited by 331 · cited 1×
“Neuroimaging structural studies have also identified alterations suggestive of microvascular damage in patients with MDD, which is characteristic of neurodegenerative disorders (Lewis, 2002; Treadway et al., 2015).”
BackgroundKlempan, T. A., Sequeira, A., Canetti, L., Lalovic, A., Ernst, C., ffrench-Mullen, J., & Turecki, G. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002110 · Cited by 294 · cited 1×
“…et al., 2011; Uranova, Vostrikov, Orlovskaya, & Rachmanova, 2004), and expression levels of genes responsible for proper functioning of oligodendrocytes were lower in the amygdala and prefrontal cortex of patients with MDD (S. Kim & Webster, 2010; Klempan et al., 2009; Sibille et al., 2009).”
BackgroundTripp, A., Oh, H., Guilloux, J.-P., Martinowich, K., Lewis, D. A., & Sibille, E. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020248 · Cited by 273 · cited 1×
“In support of this hypothesis, lower levels of BDNF (Karege, Vaudan, Schwald, Perroud, & La Harpe, 2005), expression of BDNF-regulated genes, and BDNF tyrosine receptor kinase B (TrkB) (Tripp et al., 2012) have been found in post- mortem brains from patients with MDD.”
BackgroundThe Role of Oxidative Stress in Depressive Disorders
Maria Michel, T., Pulschen, D., & Thome, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803523554 · Cited by 268 · cited 6×
“Significant reduction in glial cells is also strongly implicated in MDD, which could be contributing to reduced neuronal survival and increased vulnerability to environmental stressors (Michel et al., 2012; Rajkowska, O'Dwyer, Teleki, Stockmeier, & Miguel-Hidalgo, 2007; Sibille & French, 2013).”
BackgroundInfluentialNajjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-142 · Cited by 248
Gigante, A. D., Bond, D. J., Lafer, B., Lam, R. W., Young, L. T., & Yatham, L. N. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01033.x · Cited by 226 · cited 2×
“…and its metabolites in the anterior cingulate cortex, prefrontal cortex, amygdala, occipital cortex, and the hippocampus (Auer et al., 2000; Gigante et al., 2012; Hasler et al., 2007; Pfleiderer et al., 2003; Sanacora et al., 2004; Zhang et al., 2013), although the direction of change is…”
BackgroundSelf-citationSerotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion
Nitsch, R. M., Deng, M., Growdon, J. H., & Wurtman, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4188 · Cited by 219 · cited 2×
“One study reported that amyloid precursor protein can be stimulated to become secretory by activated serotonin receptors (Nitsch, Deng, Growdon, & Wurtman, 1996), offering a possible explanation for why amyloid pathology may be greater in patients with a history of depression (Nitsch et al., 1996).”
BackgroundGlial and glutamatergic markers in depression, alcoholism, and their comorbidity
Miguel-Hidalgo, J. J., Waltzer, R., Whittom, A. A., Austin, M. C., Rajkowska, G., & Stockmeier, C. A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.003 · Cited by 218 · cited 1×
“…acidic protein were found in the prefrontal cortex as well as lower levels of glutamate clearance transporters in astrocytes (Choudary et al., 2005; Miguel-Hidalgo et al., 2010; Si, Miguel-Hidalgo, O'Dwyer, Stockmeier, & Rajkowska, 2004), suggesting decreased functioning of glial cells as well.”
BackgroundMichel, T. M., Frangou, S., Thiemeyer, D., Camara, S., Jecel, J., Nara, K., Brunklaus, A., Zoechling, R., & Riederer, P. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.04.013 · Cited by 218
Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression
Karolewicz, B., Maciag, D., O'Dwyer, G., Stockmeier, C. A., Feyissa, A. M., & Rajkowska, G. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990587 · Cited by 203
An update on regional brain volume differences associated with mood disorders
Campbell, S., & MacQueen, G. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000194371.47685.f2 · Cited by 198 · cited 2×
“…McKeith, Gholkar, & Ferrier, 2004; Sheline, Gado, & Kraemer, 2003), prefrontal cortex (Campbell, Marriott, Nahmias, & MacQueen, 2004), anterior cingulate cortex (Savitz et al., 2010), and amygdala (Campbell & MacQueen, 2006; Hajek, Kozeny, Kopecek, Alda, & Höschl, 2008; Konarski et al., 2008).”
ResultNeuropathological correlates of late-life depression in older people
Tsopelas, C., Stewart, R., Savva, G. M., Brayne, C., Ince, P., Thomas, A., & Matthews, F. E. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.078816 · Cited by 182 · cited 3×
“Tsopelas and colleagues (Tsopelas et al., 2011) reported increased presence of subcortical Lewy bodies in patients with depression compared to healthy controls in the post-mortem frontal, parietal, temporal, entorhinal and occipital cortices, hippocampus, and the brain-stem monoaminergic nuclei,…”
BackgroundRegenold, W. T., Phatak, P., Marano, C. M., Gearhart, L., Viens, C. H., & Hisley, K. C. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.12.019 · Cited by 178 · cited 1×
“…demyelination of white matter and decreased myelin intensity staining were found in the post-mortem prefrontal cortex of patients with MDD (Regenold et al., 2007; Thomas, O'Brien, Barber, McMeekin, & Perry, 2003), suggesting that lower number of oligodendrocytes may be translating into…”
BackgroundLiukkonen, T., Silvennoinen-Kassinen, S., Jokelainen, J., Räsänen, P., Leinonen, M., Meyer-Rochow, V. B., & Timonen, M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.016 · Cited by 163
Depression and C-Reactive Protein: Population-Based Health 2000 Study
Elovainio, M., Aalto, A.-M., Kivimäki, M., Pirkola, S., Sundvall, J., Lönnqvist, J., & Reunanen, A. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31819e333a · Cited by 157 · cited 2×
“While this is the only study that examined inflammatory cytokines in the post-mortem brain of patients with MDD, their findings are in agreement with studies that examined peripheral samples (Dowlati et al., 2010; Elovainio et al., 2009; Ford & Erlinger, 2004; Liukkonen et al., 2006).”
ResultOh, D. H., Son, H., Hwang, S., & Kim, S. H. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.001 · Cited by 103
Khundakar, A., Morris, C., Oakley, A., McMeekin, W., & Thomas, A. J. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.052688 · Cited by 71
Santos, M., Gold, G., Kövari, E., Herrmann, F. R., Hof, P. R., Bouras, C., & Giannakopoulos, P. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01101.x · Cited by 32 · cited 2×
“reported a lack of association between microvascular alterations or lacunes with MDD in patients (Jellinger, 2013; Santos et al., 2010; Xekardaki et al., 2012).”
Background
Cited by
Bagheri, S., Heydari, A., Alinaghipour, A., & Salami, M. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.03.038 · Cited by 201
Salvat-Pujol, N., Labad, J., Urretavizcaya, M., de Arriba-Arnau, A., Segalàs, C., Real, E., Ferrer, A., Crespo, J. M., Jiménez-Murcia, S., Soriano-Mas, C., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.007 · Cited by 47
Walsh, B., Dahlke, S., O’Rourke, H., & Hunter, K. F. (2022) · Journal of Clinical Nursing · doi:10.1111/jocn.15477 · Cited by 11
Metadata
- Authors
- Kim, H. K., Nunes, P. V., Oliveira, K. C., Young, L. T., & Lafer, B.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 67
- Pages
- 51-57
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2257952977
- Cited by
- 108
- References
- 50
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.